Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 2 Postoperative Nausea and Vomiting 1 Pain, Postoperative 1 Pain 1 Intracranial Aneurysm 1 Hyperalgesia 1 Fibrosis 1 Diabetes Mellitus 1 Breast Neoplasms 1

Interventions

Metformin 8 Nutrition Assessment 3 Methods 3 Exercise 3 Educational Status 3 Tirzepatide 2 Therapeutics 2 Tablets 2 Resistance Training 2 tocilizumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 saxagliptin 1 otelixizumab 1 esmolol 1 epalrestat 1 donafenib 1 dapagliflozin 1 amlodipine, atorvastatin drug combination 1 Verapamil 1 Surveys and Questionnaires 1 Standard of Care 1 Secretin 1 Second Harmonic Generation Microscopy 1 Risk Assessment 1 Remote Consultation 1 Preventive Health Services 1 Practice Guidelines as Topic 1 Patient Navigation 1 Pancreaticoduodenectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Diabetes Mellitus × esmolol × Clear all

NCT05769868 2024-10-01

CIBERbBECHO

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Phase 3 Recruiting

Diabetes Mellitus, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡